RFL
Rafael Holdings Inc
$
1.600
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
1.600
Open
1.600
VWAP
1.60
Vol
216.00
Mkt Cap
56.85M
Low
1.600
Amount
345.60
EV/EBITDA(TTM)
--
Total Shares
24.57M
EV
23.54M
EV/OCF(TTM)
--
P/S(TTM)
54.65
Rafael Holdings, Inc. is a biotechnology company. The Company holds interests in clinical and early-stage pharmaceutical companies, including a 100% interest in Cyclo Therapeutics, LLC, a biotechnology company focusing on developing its lead clinical candidate, Trappsol Cyclo, which is being evaluated in clinical trials, including an ongoing Phase III trial for the potential treatment of Niemann-Pick Disease Type C1 (NPC1), a rare, fatal, and progressive genetic disorder. It also holds an interest in LipoMedix Pharmaceuticals Ltd., a clinical-stage pharmaceutical company; Barer Institute Inc., a wholly owned preclinical cancer metabolism research operation, and an interest in Cornerstone Pharmaceuticals, Inc., a cancer metabolism-based therapeutics company. It holds an interest in Rafael Medical Devices, LLC, an orthopedic-focused medical device company developing instruments to advance minimally invasive surgeries, and a majority interest in Day Three Labs, Inc.
Show More
Valuation Metrics
The current forward P/E ratio for Rafael Holdings Inc (RFL.N) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Rafael Holdings Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00
Financials
Annual
Quarterly
FY2025Q3
YoY :
+7.74%
362.00K
Total Revenue
FY2025Q3
YoY :
-93.65%
-5.91M
Operating Profit
FY2025Q3
YoY :
-93.50%
-4.05M
Net Income after Tax
FY2025Q3
YoY :
-85.82%
-0.19
EPS - Diluted
FY2025Q3
YoY :
+720.05%
-3.19M
Free Cash Flow
FY2025Q3
YoY :
+61.94%
71.82
Gross Profit Margin - %
FY2025Q3
YoY :
+29.22%
-1.57K
FCF Margin - %
FY2025Q3
YoY :
-93.96%
-1.12K
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
1
16.7M
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
1
16.7M
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
RFL News & Events
Events Timeline
2025-06-18 (ET)
2025-06-18
07:05:54
Rafael announces continuation of Phase 3 TransportNPC study following DMC review
2025-06-11 (ET)
2025-06-11
07:02:57
Rafael Holdings reports Q3 EPS (19c) vs ($1.36) last year
2025-05-05 (ET)
2025-05-05
07:15:35
Rafael announces revised subscription rights in connection with offering
Sign Up For More Events
Sign Up For More Events
News
9.0
06-18NewsfilterRafael Holdings Announces Continuation of its Phase 3 Study for the Treatment of Niemann-Pick Disease Type C1 (NPC1) Following Independent Data Monitoring Committee (DMC) Review of Prespecified 48-Week Interim Data
4.5
06-12NASDAQ.COMThursday Sector Leaders: Precious Metals, Real Estate Stocks
8.5
06-04NewsfilterRafael Holdings, Inc. Announces Final Results and Closing of Rights Offering
Sign Up For More News
People Also Watch
LOOP
Loop Industries Inc
1.580
USD
0.00%
DUOT
Duos Technologies Group Inc
6.060
USD
0.00%
MSAI
MultiSensor AI Holdings Inc
0.784
USD
+0.51%
LBGJ
Li Bang International Corporation Inc
1.200
USD
-3.33%
WWR
Westwater Resources Inc
0.678
USD
-4.24%
ICCC
ImmuCell Corp
6.660
USD
0.00%
UG
United-Guardian Inc
7.850
USD
0.00%
ESGL
ESGL Holdings Ltd
2.840
USD
0.00%
SPAI
Safe Pro Group Inc
3.940
USD
+2.07%
BHM
Bluerock Homes Trust Inc
13.370
USD
-1.47%
FAQ
What is Rafael Holdings Inc (RFL) stock price today?
The current price of RFL is 1.6 USD — it has decreased -1.23 % in the last trading day.
What is Rafael Holdings Inc (RFL)'s business?
What is the price predicton of RFL Stock?
What is Rafael Holdings Inc (RFL)'s revenue for the last quarter?
What is Rafael Holdings Inc (RFL)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Rafael Holdings Inc (RFL)'s fundamentals?
How many employees does Rafael Holdings Inc (RFL). have?